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薬物代謝工学部門 Departmentof Metabolic Engineering 
教授 服部 征雄 ProfessorMasao Hattori (Ph.D.) 
助教授 横津 隆子 AssociateProfessor Takako Yokozawa (Ph. D.) 
助手 宮代 博継 AssistantProfessor Hirotsugu Miyashiro (Ph. D.) 
技官 中村 憲夫 ResearchAssociate Norio Nakamura (Ph.D.) 
薬物代謝工学部門は和漢薬の薬効，毒性発現に関与する代謝系の分子生物学的研究を発展させる
ことを設置目的とし，①和漢薬の薬効発現に関与する腸内細菌遺伝子の解析，②薬物代謝機能調
節遺伝子の解明とその応用，③腎毒性物質産生機構の分子生物学的解明とその制御に関する研究を
課題として取りあげ，和漢薬の薬効発現機構，生体へのレスポンスなどの基礎的研究を通じて，和
漢薬の科学的評価や臨床応用をはかることを目指している。主な研究題目を以下に示す。
1. 天然物のバイオトランスフォーメイション
2. 和漢薬の薬効発現に関与する腸内細菌遺伝子の解明
3. AIDSの予防および治療薬の開発
4. 腎疾患における病態の解明と腎臓病治療薬の開発
本年度の主な研究を列挙すると：
1. ヒト腸内細菌による phorbolの変換を検討し，この化合物が容易に開裂反応を経て種々の代
謝物に変換されることを明らかにした。
2. HIV－インテグラーゼ阻害活性を指標にタイ薬用植物 50種のエキスを探索し， Coleus
parvifolius, Thevetia per・uvianαなどに強い酵素阻害活性を見出した。又， これらのエキス
から阻害活性成分を単離しその阻害様式を検討した。その他， 180種のフラボン類のインテグ
ラーゼ阻害活性を検討し，活性と活性相関を調べた。
3. 中国少数民族使用薬物およびタイ薬用植物の抗ヘルぺスウイルス活性を探索した。また， C
型肝炎ウイルス由来のRNAポリメラーゼ阻害活性もあわせ検討した。
4.増悪因子のラジカルの関与について，地検，ソノ丸薬用人参サポニン，丹参成分magnesium
lithospermate B，漢方方剤温牌湯の腎における役割を解析した。また糖尿病性腎症のモデル
を構築し漢方方剤の効果を究明した。
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く〉著書 Books
1）服部征雄，中村憲夫：抗HIV活性を有する伝統薬物．『薬用植物・生薬開発の最前線J，佐竹元吉監修，
株式会社シーエムシー，東京， 2001,pp. 299-320. 
2) Yokozawa T.: Role of the Active Dan Shen Component, Magnesium Lithospermate B, in the Kidney. 
”Molecular Aspects of Asian Medicines”， edited by A. Mori and T. Satoh, PJD Publications Ltd., New 
York, 2001, pp.139-155. 
く〉原著 Originalpapers 
1) Tezuka Y., Terazono M., Kusumoto T., Hatanaka Y., Kadota S., Hattori M., Namba T., 
Kikuchi T., Tanaka K., and Supriyatna S.: Helicterins A-F, six new dimeric (7.5’， 8.2’）－ 
neolignans from the Indonesian medicinal plant Helicteres isora. Helv. Chim. Acta, 83: 2908・
2919, 2000. 
（研究所年報 27巻 62頁 18参照）
2) Song S. J., Nakamura N., Ma C. M., Hattori M., and Xu S. X.: Five saponins from the root 
bark of Aralia elata. Phytochemistry, 56: 491-497, 2001. 
Five new saponins, 3-0・｛β－D-glucopyranosyl(1→2）・［β心－glucopyranosyl1→3）］， βーD-glucopyranosyl}oleanolic 
acid 28・0－βーD-glucopyranosylester (aralia-saponin V), 3-0・｛β心－glucopyranosyl(1→2）－［β－D・glucopyranosyl( 1 
→3）］－β－D-glucopyranosyl }echinocystic acid 28・0－β－D-glucopyranosylester (aralia-saponin VI), 3-0－｛ β－D-
glucopyranosyl ( 1→2）－［β－D闇glucopyr osyl (1→3）］－β－D白glucopyranosyl}hederagenin28-0－β’－D-glucopyr osy 1 
ester (aralia-saponin VII), 3-0－｛β・D-glucopyranosyl-(1→3）－β－D-glucopyranosyl・(1→3）ー［β－D-glucopyranosyl-(1 
→2）］・β－D-glucopyranosyl}caulophyllogenin 28-0－βーD-glucopyranosylester (aralia-saponin VIII), 3-0司｛/3・D-
glucopyranosyl ( 1→2）ー［βーD-glucopyranosyl(1→3）］ー αーL-arabinopyranosyl}hederagenin 28-0－β心，glucopyranosyl
ester (aralia-saponin IX), were isolated from the root bark of Aralia elata (Miq.) Seem., together with four known 
compounds. Their structures were determined on the basis of chemical and spectroscopic methods. 
3) Ma C., Nakamura N., Min B., and Hattori M.: Triterpenes and lignans from Artemisia 
caruifolia and their cytotoxic effects on Meth・Aand LLC tumor cell lines. Chem. Pharm. 
Bull., 49: 183-187, 2001. 
One new凶te中ene,3β－hydroxy-29-norcycloart-24-one (1), and four new 
lignans, caruilignans (2・5),together with six known compounds were iso-
lated from the aerial p制 ofArtemisia caruifolia Buch.-Ham. ex Toxb. Their 
structures were determined by various spectroscopic means. Most of the iso-
lated lignans were moderately cytotoxic to Meth-A cells with EDso values of 
5-10 μg/ml, but not to Lowis lung carcinoma (LLC) cels. An oxime deriva-
tive of 1 showed more potent cytotoxic activity against Meth-A and LLC 
cels than the original triterpene 1 (see Fig. 1). 
4) Min B., Tomiyama M., Ma C., Nakamura N., Hattori M.: 
Kaempferol acetylrhamnosides from the rhizome of 
Dryopteris crassirhiwma and their inhibitory effects on 
three different activities of human immunodeficiency virus-
1 reverse transcriptase. Chem. Pharm. Bull., 49: 546・550,
2001. 
Three new kaempferol glycosides, called crassirhizomosides A (1), B (2) and 
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C (3), were isolated from the rhizome of Dryopteris crassirhiwma (Aspidiaceae ),together with the known 
kaempferol glycoside, sutchuenoside A (4). The structures of 1-3 were determined as kaempferol 3・α－L-(2,4-di・0・
acetyl) rhamnopyranoside-7－α－L-rhamnopyranoside, kaempferol 3・αーL-(3,4・di-0-acetyl)rh担nnopyranoside四7－α－L-
rhamnopyranoside, and kaempferol 3－α－L-(2,3・di・0白acetyl)rhamnopyranoside-7・α－L-rhamnopyranoside,respectively, 
by chemical and spectroscopic means. Inhibitory effects of 1-4 and kaempferol on HIV reverse transcriptase-
associated DNA polymerase (RNA-dependent DNA polymerase and DNA-dependent DNA polymerase) and RNase 
H activities were investigated. 
5) Zhao J., Yang X., and Hattori M.: Three new triterpene saponins from the seeds of Aesculus 
chinensis. Chem. Pharm. Bull., 49: 626・628,2001. 
Three new triterpenoid saponins were isolated from the seeds of Aesculus chinensis, and characterized as 22-
tigloylprotoaescigenin 3・0・［ βーD-glucopyranosyl( 1→2)][ β－D・glucopyranosyl(1→4）］ーβ－D-glucopyranosiduronic 
acid (escin IVg, 1), 22-angelo）匂roto-aescigenin3-0司［β－D-glucopyranosyl(1→2）］［β心－glucopyranosyl(1→4）］・
βーD”glucopyranosiduronic acid (escin IVh, 2) and 16-angeloyl・21-acetylproto-aescigenin3・0－［β，D-glucopyranosyl
(1→2)] ［β－D-glucopyranosyl (1→4）］－β－D-glucopyranosid uronic acid (escin Vlb, 3), together with two known 
compounds, escin Illa (4) and desacylescin I (5). Their structures were established on the basis of spec仕oscopicand 
chemical evidence. 
6 ) Meselhy R. M., Nishimoto E., Akao T .,and Hattori M.: Transformation of shikonin by a cell-
free extract of Eubacterium sp. A・44,a human intestinal bacterium. J. Trad. Med., 18: 58・63,
2001. 
For the pu叩oseof investigating the metabolic processes of shikonin (1) by human intestinal bacteria, we prep紅ed
a sonicated bacterial cel suspension and a crude enzyme prep訂ationfrom Eubacterium sp. A・44,one of the intes-
tinal bacteria capable of transfoロning1 to various metabolites. After anaerobic incubation with the suspension for 
1 hr, most of 1 was transformed to prometaboshikonin (2), and metaboshikonins I (3) and I (4). However, under 
aerobic conditions, the dimers, shikometabolins A (5) and B (6), were predominantly formed. In the presence of the 
crude enzyme prep紅ation,formation of 2-4 was inhibited by oxygen, but markedly enhanced by the addition of 
NADH. On the other hand, formation of 5 and 6 was appreciably accelerated by the addition of NAD+. In the ab-
sence of the crude enzyme prep訂ation,NADH and/or NAD+ showed no ability to transform 1 to the any metabo-
lites, as in the case of a thermally inactivated preparation. Accordingly, the two different metabolic processes leading 
to compounds 2-4 and compounds 5 and 6 by Eubacterium sp. A-44訂econcluded to be enzyme-dependent in由e
presence of NADH and NAD+. 
7 ) Ma C., Nakamura N., Hattori M.: Inhibitory effects on HIV・1 protease of tri・p・
coumaroylspermidine from Artemisia caurifolia and related amides. Chem. Pharm. Bull., 49: 
915・917,2001. 
From a methanol extract of Artemisia caruif olia, which showed a moderate inhibitory activity on HIV-1 protease in 
a preliminary screening, N1, N5, N10-tri-p-coumaroylspermidine and three dicaffeoylquinic acids were isolated. The 
former compound was found to appreciably inhibit HIV-1 protease. Of related amides which were chemically syn-
thesized, N1, N5, N19, N14-tetra帽p-coum紅oylspermineand N1, N4, N7, N10, N13-penta・p-coumaroyltetraethylenepentamine 
inhibited HIV-1 protease more potently than N1, N5, N10-tri-p-coumaroylspermidine. 
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8) Abdel・HafezA. A., Meselhy M. R., Nakamura N., Hattori M.: New paeonilactone-A adducts 
formed by anaerobic incubation of paeoniflorin with Lactobacillus brevis in the presence of 
arylthiols. Chem. Pharm. Bull., 49: 918-920, 2001. 
During the course of preparing anticonvulsant paeonimetabolin-1 adducts, new paeonilactone-A adducts: 9-
phenylthiopaeonilactone-A, 9・（o-tolylthio)paeonilactone-A,9・（m-tolylthio)paeonilactone-A,9・(p-tolyl由io)paeonilactone-
A and 9・（2-naphthylthio)paeonilactone-A,were obtained along with expected paeonimetabolin-1 adducts by anaero-
bic incubation of paeoniflorin from peony roots with Lactobacillus brevis in the presence of the aromatic thiols, 
phenyl由iol,o-tolylthiol, m-tolylthiol, p-tolylthiol and 2-naphthylthiol. The s住ucturesof these compounds were de-
termined by spectroscopic methods including 2D NMR. 
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9 ) Abdel-Sattar E., Abdul・AzizAl-Yahya M., Nakamura N., and Hattori M.: Penicillosides A-C, 
C-15 oxypregnane glycosides from Caralluma penicillata. Phytochemistry, 57: 1213-1217, 2001. 
The chloroform fraction of the defatted ethanol extract from the aerial parts of Caralluma penicillata yielded three 
new C-15 oxypregnane glycosides. The s佐ucturesof the isolated compounds were established by a combination of 
spectroscopic methods. 
10) Murakami T., Kishi A., Matsuda H., Hattori M., and Yoshikawa M.: Medicinal foodstuffs. 
XXIV. Chemical constituents of the processed leaves of Apocynum venetum L.: absolute 
stereostructures of apocynosides I and I. Chem. Pharm. Bull., 49: 845・848,2001. 
Two new ionone glucosides, named apocynosides I and I, were isolated from the roasted leaves of Apocynum 
venetum L. toge出erwith nine known compounds. The absolute stereostructures of apocynosides I and I were deter-
mined by chemical and physicochemical evidence, which included the application of a modified Mosher’s method 
and the circular dichroism helicity rule. 
11) Min S., Gao J., Nakamura N., Kim Y., and Hattori M.: Cytotoxic alkaloids and a flavan from 
the bulbs of Crinum asiaricum var. japonicus. Chem. Pharm. Bull., 49: 1217・1219,2001. 
A new pyπolophenant勘idonealkaloid, criasiacitidine A (1), was isolated from the bulbs of Crinum asiaticum var. 
japonicum, together with pratorimine (2), lycorine (3) and 4’－hydroxy-7叩 ethoxyflavan( 4).The s加 ctureof the new 
alkaloid was determined to be 4,5唱theno-9,10-dihydroxy-6-phenanthridoneby spectroscopic means. The cytotoxicity 
of the isolated compounds 1-4 was evaluated in vitro against Meth-A (mouse sarcoma) and Lewis lung careinoma 
(mouse lung carcinoma) tumor cel lines. Furthermore, lycorine (3) was examined for in vivo antitumor activity with 
LLC tumor cels. 
12) Gao J., Min B., A匙aoT .,Meselhy R. M., Nakamura N .,and Hattori M.: Enzyme immuno-
assay for the quantitative determination of ganoderic acid A from Ganoderma lucidum. J. 
Trad. Med., 18: 154圃160,2001. 
For quantitative determination of ganoderic acid A (GAA, 1), a m司orconstituent of Ganoderma lucidum, a sensitive 
and specific enzyme immunoassay (EIA) system was developed; the side chain of GAA was extended by introducing 
a glycine moiety, and this compound was coupled with β国D-galatosidase（β－Gal) and bovine serum albumin (BSA) 
via an N-hydroxysuccinimide ester to give GAA－β－Gal (enzyme-labeled antigen, 5) and GAA-BSA (immunogen, 
6), respectively. The anti-GAA antiserum, which had been elicited in rabbits by immunization with the GAA-BSA 
conjugate, possessed high affinity and specificity toward GAA, when the assay was C紅Tiedout with a double anti-
body technique. A satisfactory standard curve for EIA of GAA was explored in a range of 0.1 -I 000 ng/tube. The 
antiserum of GAA was no cross-reactivity with GAA-related compounds isolated from G. lucidum, except for 
ganoderic acid r (11) and ganolucidic acid A (14) with cross-reactivity of 52.4 and 12.9%, respectively, due to its 
close similarity in structure to GAA (ganoderic acid derivatives having a carbonyl group at C-3) . The plasma con-
centration of GAA after its intravenous or oral administration to rats was determined by the established EIA. The 
AUCs after intravenous administration of GAA were 32.8 ± 9.8 and 201.5 ± 38.7 μg min/ml at doses of 5 and 25 
mg/kg, respectively. Following oral administration of GAA at doses of 5 and 50 mg/kg to rats, the plasma concen-
tration of GAA rapidly reached a Cmax (37 and 595 ng/ml) at 18.1 ± 2.5 and 18.0 ± 0.6 min, respectively, then de-
creased to 4.2 and 13.3 ng/ml at 480 min, respectively, indicating that GAA was rapidly absorbed into the body fluid 
from the gastrointestinal tract after the oral administration, and then decreased soon. 
13) Meselhy R. M., Nishimoto E., Akao T., and Hattori M.: Human intestinal Bacteroides spp. 
RHEIN・Iand RHEIN-II capable of transforming rhein to rheinanthrone, induce rhein・
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dependent diarrhea in rats. J. Trad. Med., 18: 169・176,2001. 
Two rhein-metabolizing bacteria were isolated from human feces. The biochemical and mo中hologicalcharacteris-
tics of both isolates were typical of Bacteroides spp. and named strains RHEIN-I and RHEIN-II, respectively. Rhein 
was effectively metabolized to rheinanthrone by both 位制ns.In conventional male Wistar rats, diarrhea was not in・
duced after oral adminis住ationof rhein at a dose of 100 mg/kg (fecal water content of 71 % ),in spite of severe di-
arrhea with sennoside Bat a dose of 40 mg/kg, increase of fecal water content to 89%. Also in Germ-free rats, rhein 
did not induce組 ydiarrhea. Gnotobiote rats colonized with B. sp. strain RHEIN-I developed di出Thea(fecal water 
content increased to 85%) 11 hr after the oral administration of rhein. These findings indicate that rhein-transforming 
bacteria紅eresponsible for the laxative effect associated with the ingestion of rhein組 drhein containing prep町a-
tlons. 
14) Marpaung L., Nakamura N., Kakuda H., and Hattori M.: Absolute configuration of cipadesin 
and febrifugin from the seeds of Cipadessa baccifera. Natural Med., 55: 220, 2001. 
Two tetranortriterpenoids, cipadesin組 dfebrifugin, were isolated from the seeds of Cipadessa baccif era. Their ab-
solute structures were elucidated by spec住oscopicand X-ray method. 
15) Nawawi A., Nakamura N., Meselhy M. R., Hattori M., Kurokawa M., Shiraki K., Kashiwaba 
N., and Ono M.: In vih・oantiviral activity of Stephania cepharantha against herpes simplex 
virus type-1. Phytother. Res., 15:497-500, 2001. 
The antiviral activity of a MeOH ex佐actof Stephania cepharantha (root tubers), its CHCb-soluble fraction (alkaloid 
fraction) and the major alkaloid FK-3000 (1) was investigated in BALB/c mice cutaneously infected with HSV-1 
strain 7401H. At doses of 125 and 250 mg/kg body weight, p.o.，出eMeOH extract significantly delayed skin lesion 
on score 2 (vesicles in the local region), limited the development of further lesions on score 6 (mild zosteriform le-
sion), and prolonged the mean survival time of HSV・1infected mice. After p.o. administration of the CHCh-solubie 
fraction at doses of 25 and 50 mg/kg or PK・3000(1) at 10 and 25 mg/kg, similar results were obtained. Although 
the alkaloid improved survival of infected mice, it had a narrow therapeutic index. 
16) Min B., Kim Y., Tomiyama M., Nakamura N., Miyashiro H., Otake T., and Hattori M.: 
Inhibitory e町ectsof Korean plants on HIV・1activities. Phytotheれ Res.,15: 481・486,2001. 
In the search for novel anti-human immunodeficiency virus type 1 (anti-HJV-1) agents from natural sources, 49 
MeOH extracts of Korean plants were screened for their inhibitory effects against RNA-dependent DNA 
polymerase (RT) and ribonuclease H (RNase H) activities of HIV-1 reverse transcriptase and HIV-1 protease, and 
anti-HIV・1activity. Regarding the HIV-1 reverse transcriptase, Agrimonia pilosa (whole plant), Comus kousa (s胞m
and leaf), Limonium tetragonum (root) and Mallotus japonicus (stem) showed significant inhibitory activity on RT 
activity with 50% inhibitory activity (ICso) of 8.9, 6.3, 7.5 and 11.9 mg/mL, respectively, whereas Agrimonia pilosa 
was also active against RNase H activity (ICso = 98.4 mg/mL). Four plants, namely Agrimonia pilosa (whole plant), 
Atractylodes japonica (root), Clematis heracleifolia (whole plant) and Syneilesis palmata (whole plant), were appre-
ciably active （く35%)against recombinant HIV・1protease at a concentration of 100 μg/mL. Crinum asiaticum var. 
japonicum (root) showed significant anti-HIV・1activity (EDso = 12.5 μg/mL) with a favourable SI value of 16. 
17) Wang L., Meselhy M.R., Li Y., Nakamura N., Min B., Qin G., and Hattori M.: The 
heterocyclic ring fission and dehydroxylation of catechins and related compounds by 
Eubacterium sp. strain SDG・2,a human intestinal bacterium. Chem. Phann. Bull., 49: 1640・
1643, 2001. 
A human intestinal bacterium, Eubacterium (E.) sp. strain SDG-2, was tested for its ability to metabolize various (3 
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R)-and (3S)-flavan-3-ols and their 3・0・gallates.This bacterium cleaved the C-ring of (3R)-and (3S)-flavan・3-olsto 
give 1,3-diphenylpropan-2・olderivatives, but not heir 3・0・gallates.Furthermore, E. sp. str泊nSDG・2had the ability 
of p-dehydroxylation in the B-ring of (3R)-flavan-3・ols,such as （ー）－catechin,(-)-epicatechin, （・）－galloca旬chinand 
（・）－epigallocatechin,but not of (3S)・flavan・3・ols,such as ( ＋）・catechinand (+)-epic剖.echin.
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18) Wang L., Min B., Nakamura N., Qin G., Li C., and Hattori M.: Cytotoxic mono-
tetrahydrofuran ring acetogenins from leaves of Annona montana. Planta Med., 67: 847・852,
2001. 
Further studies on leaves of Annona montana led to isolation of one iso・acetogenin,montanacin G, three pairs of 
acetogenins, montanacins H-J and 34・epi-montanacinsH-J, toge由erwith four known acetogenins, gigantetrocins A 
and B, annonacin and cis-annonacin. Montanacin G belongs to the iso-acetogenin group with a terminal 2,4-trans-
ketolactone unit. Montanacins H-J and 34-epi-montanacins H-J contain the rare r・hydroxy-r伺methyl－’Y-lactone 
moiety. The cytotoxic activities of these compounds, toge出erwith previously reported acetogenins, montanacins B 
and C, were examined against Meth-A and LLC tumor cel limes in vitro. 
19) Quyang X., Takahashi k., Komatsu K., Nakamura N., Hattori M., Baba A., and Azuma J.: 
Protective effect of Salvia miltio"hiza on angiotensin II-induced hypertrophic responses in 
neonatal rat cardiac cells. Jpn.よPharmacol., 87: 289・296,2001. 
The effect of the root of Salvia miltiorrhiza (SM) on angiotensin I (Ang I）・inducedhypertrophic responses was ex-
amined in cultured neonatal rat cardiac cels ( cardiomyocytes and norトcardiomyocytes).The methanol eluate frac-
tion (SM2) of the water extract and the ethyl acetate-insoluble fraction (SM3) and its soluble fraction (SM4) 
partitioned from the methanol extract were prep訂・ed.Treatment with SM4 (5-80 μg/ml), not SM2 and SM3, for 24 
h produced dose-dependent cytotoxicity against cardiac cells relative to the reduction in viability and the mo中ho・
logical in ury of cardiomyocytes. SM2 or SM3 in the absence of Ang I affected neither hyperplastic nor 
hypertrophic growth of both cel types. However, SM3 (40 μg/ml) attenuated the positive chronotropic responsive-
ness of cardiomyocytes to Ang I (1 nM) stimulation, whereas Ang II-induced increase in non-cardiomyocyte num-
ber was decreased only by SM2 (40 μg/ml) treatment. Furthermore, SM3 suppressed Ang II-induced enlargement of 
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cel size by preceding Ang II-induced induction of immediate early response gene (cゾun)expression in 
cardiomyocytes, while SM2 decreased Ang II-indused DNA synthesis in non-cardiomyocytes. Moreover, three 
phenolic compounds and tanshinone IIA出atdiffered quantitatively among three SM fractions were identified by re-
verse-phase high performance liquid chromatography. Thus, the present findings indicate that出eroot of SM isan 
effective inhibitor of Ang I action and has a plural effective constituent, which possess different pharmacological 
activities on Ang II-induced hypertrophy and hyperplasia in cultured neonatal rat cardiac cels. 
20) Supinya T., Miyashiro H., Hattori M., Yoshinaga T., Fujiwara T., Tomimori T., Kizu H., and 
Miyaichi Y .:Inhibitory e住民tsof flavonoids on human immunodeficiency virus type-1 
integrase. J. Trad. Med., 18, 229・238,2001. 
One hundred and eighty-three flavonoids were screened for their inhibitory effects on HIV-1 integrase (IN) using a 
multiplate integration assay (MIA). Of the tested flavonoids, 6-hydroxyluteolin, scutellarein, pedalitin, scutellarin, 
baicalein dimer, hypolaetin, 7-0・benzyl-6-hydroxyhiteolinand baicalein showed appreciable inhibition with ICso 
values of 0.4, 0.6, 1.3, 1.7, 2.0, 2.1, 3.0 and 3.6 μM, respectively. The potent inhibition was observed with 
flavonoids having at least one pair of vicinal hydroxyl groups and the activity was highly dependent on the number 
of vicinal hydroxyl groups. On the other hand, the inhibitoηactivity tended to be decreased by replacing a hydroxyl 
group with one of methoxyl, acetoxyl, isopropoxyl, isopentenyl, benzyloxyl, glucutonyl and glycosyl groups. No 
flavanones, flavanonols and chalcones examined in this experiment showed any significant inhibitory activity. 
21) Yokozawa T., Fujii H., Kosuna K., and Nonaka G.: EfTec飴 ofbuckwheat in a renal ischemia-
reperfusion model. Biosci. Biotechnol. Biochem., 65: 396・400,2001. 
Experiments were done to find whether buckwheat extract ameliorates the renal injury induced by ischemia-
reperfusion. In ischemic叩 perfusedcontrol rats, the activities of antioxidative enzymes in renal tissue and blood and 
renal parameters deviated from the normal r組 ge,indicating dysfunction of the kidneys. In contrast, when buckwheat 
extract was given orally for 20 consecutive days before ischemia and reperfusion, the activities of the antioxidation 
enzymes superoxide dismutase, catalase, and glutathione peroxidase were higher, while thiobarbituric acid-reactive 
substance levels in serum and renal tissue were lower in the treated rats than in the contr:ols. Decreased levels of urea 
nitrogen and creatinine in serum demonstrated a protective effect against the renal dysfunction caused by ischemia 
and recirculation. On the other hand, it was demonstrated that buckwheat extract had a protective effect on cultured 
proximal tubule cells subjected to hypoxia-reoxygen剖ion,probably by preventing oxygen free radicals from attack” 
ing the cel membranes. 
22) Chen C.P., Yokozawa T., Sekiya M., Hattori M., and Tanaka T.: Protective effect of 
Sanguisorbae Radix against peroxy凶trite-mediatedrenal injury. J. Trad. Med., 18: 1・7,2001. 
3・Nitrotyrosine,an oxidative product of protein that is produced via peroxyni住ite(ONOO・） nitration, was detected 
by HPLC analysis in plasma obtained from rats i吋ectedwith lipopolysaccharide (LPS) and subjected to renal 
ischemia followed by reperfusion (LPS + ischemia-reperfusion), but not in rats subjected to sham-treatment. Rats 
pretreated with Sanguisorbae Radix ex位actorally for 30 days before LPS + ischemia-reperfusion, had lower 3-
nitrotyrosine levels th組 ratswithout the pretreatment. Plasma levels of urea nitrogen and creatinine, indicators of 
renal dysfunction, were markedly lower in the animals pretreated with Sanguisorbae Radix extract than in those 
without the pretreatment. In addition, DNA fragmentation in renal tissues was significantly inhibited by administra-
tion of Sanguisorbae Radix prior to LPS + ischemia-reperfusion. These results suggest血atSanguisorbae Radix ex-
tract ameliorates oxidative damage caused by ONoo-. 
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23) Yokozawa T., Chen C. P., and Hattori M.: Confirmation that Luobuma ameliorates the dete-
rioration of antioxidant defense in senescence-accelerated mice. J. Trad. Med., 18: 27-32, 2001. 
To determine whether Luobuma extract ameliorates the deterioration in antioxidant defense with aging, the effect of 
Luobuma extract was investigated in senescence-accelerated mice (SAM). In comparison with AKR/N Slc mice, a 
strain consistent with SAM but exhibiting normal aging, SAM treated with extract showed a lower glutathione 
(GSH）組dgluta血ione/glutathionedisulfide (GSH/GSSG) ratio in the liver and kidney, and increased levels of 
malondialdehyde (MDA), a lipid peroxidation product. Administration of Luobuma ex甘actincreased the GSH level 
and GSH/GSSG ratio, and suppressed MDA production. On the other hand, the reduced activities of hepatic 
sup~roxide dismutase (SOD), glutathione peroxidase and gluta出ionereductase p紅ticipatingin白eglutathione redox 
cycle were increased significantly by administration of Luobuma extract. A significant increase in renal SOD activity 
was also observed. In addition, the increased level of MDA in hepatic tissue was reduced in SAM given Luobuma 
extract. These findings indicate that Luobuma extract helps to ameliorate oxidative stress in SAM. 
24) Yokozawa T., Nakagawa T., and Terasawa K.: E佐ec臼 ofOriental medicines on the produc・
tion of advanced glycation endproducts. J. Trad. Med., 18: 107・112,2001. 
Advanced glycation endproducts (AGEs）訂elargely involved in the pa出ogenesisof diabetic nephropathy. It is ap-
p町・ent出atinhibition of AGEs formation is important in preventing the occurrence and progression of nephropathy. 
Therefore, to seek possible AGEs inhibitors in Oriental medicines, we began our investigation with an in vitro 
evaluation system. Among the 12 Oriental medical prescriptions examined, Ompi-to inhibited AGEs formation to the 
greatest extent, followed by Tokaku-zyoki-to and Keish1-bukuryo-gan and Daio-botampi-to in that order. Among the 
21 component galenicals examined, Rhei Rhizoma, Cinnamomi Cortex, Moutan Cortex and Paeoniae Radix al had 
a potent inhibitory action, indicating that Rhei Rhizoma, vascular system disturbance-eliminating drugs and tannin-
containing crude drugs can al inhibit the formation of AGEs.百ieseOriental prescriptions and component galenicals 
proved to have more potent inhibitory activity出anthe positive control aminoguanidine. 
25) Huh J. I., Kim H.J., Kim J. W., Shim K. H., Kim Y. J., Lee K. H., Yokozawa T., Yu B. P., 
and Chung H. Y.: Influence of aging and dietary restriction on renal nitric oxide synthase. 
Kor. J. Gerontol., 11: 28-33, 2001. 
Nitric oxide (NO) plays an important physiological roles: the control of vascular tone, the contraction of gastrointes-
tinal organs, neurotransmission via activation of soluble guanylate cyclase (sGC), and also the gene transcription via 
activation or deactivation of many transcription factors, at the molecular level. The purpose of this study was to ex-
amine whether or not aging and dietary restriction (DR) could influence the activity of NO synthase (NOS) and NOS 
gene expression in rat kidney. To estimate the gene expression of endothelial NOS, we determined mRNA levels and 
protein levels with RT-PCR and western blot analyses, respectively. Renal NOS activity in DR rats showed a gradual 
increase up to 18 months of age, but only a slight decrease at 24 months of age in ad libitum (AL) rats. Furthermore, 
DR rats showed higher mRNA levels and protein amounts than AL rats at al ages studied. These results suggest that 
DR can provide a stimulus for the enhanced production of NOS and thereby DR possibly provides beneficial effects 
to vascul訂 andrenal function during aging. 
26) Yokozawa T., Rhyu D. Y., and Owada S.: Increase of radical in rats with adenine-induced 
renal failure is suppressed by Wen-Pi-Tang. J. Trad. Med., 18: 147・153,2001. 
We analyzed the free radical reaction in the body in vivo under the conditions of renal failure, using an L-band elec-
tron spin resonance apparatus. In rats with adenine-induced renal failure, the attenuation velocity of 3・carbamoyl-
2ム5,5-tetramethy lpyrrolidine-N幽oxylwas lowered in comparison with normal rats, indicating that they were in a 
state of augmented oxidation. In contrast, the attenuation velocity was higher in rats given Wen-Pi-Tang, showing 
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a shift toward reduction. In the kidney of rats given Wen-Pi-Tang, we also found that a significant decrease in 
gluta血ionedisulfide (GSSG) level caused an increase in the glutathione/GSSG ratio. In addition, there were signifi-
cant reductions of increased thiobarbituric acid-reactive substance level and decreased superoxide dismutase and in-
creased glutathione peroxidase activities, suggesting a decreased hydrogen peroxide production, which presumably 
drove the glutathione redox cycle toward reduction.τbe results of出epresent study suggest the possibility that Wen-
Pi-Tang exerts an antioxidant effect伽 oughregulation of the redox cycle. 
27) Nakagawa T., Yokozawa T., and Terasawa K.: A study of Kampo medicines in a diabetic 
nephropathy model. J. Trad. Med., 18: 161・168,2001. 
The effects of four Kampo medicines, Ompiべo,Hachimiサio・gan,Keishi-bukuryo-gan and Sairei-to, were investi-
gated in rats with diabetic nephropathy induced by subtotal nephrectomy and injection of streptozotocin. To_ evaluate 
their effects on the glycation reaction, excessive activity of the polyol pathway and oxidative s位・es(abnormal bio-
chemical processes induced by persistent hyperglycemia), we determined levels of the m司orendproducts of these 
processes: advanced glycation endproducts (AGEs) and sorbitol in the kidney and lipid peroxidation in the serum. 
These three processes were al enhanced in rats with untreated diabetic nephropathy. Oral administration of al four 
medicines significantly lowered AGEs levels. The renal sorbitol concentration was significantly lowered in the 
Hachimi-jio・gan-,Sairei-to-and Keishiゐukuryo-gan-treatedgroups comp紅edwith the untreated control group. 
Serum lipid peroxidation was significantly lowered in the Keishi-bukuryo-gan, Ompi-to and Sairei-to groups, while 
creatinine clearance and urinary protein excretion (parameters of renal function) were ameliorated by Keishi-
bukuryo-gan and Hachimi-jio-gan, respectively, indicating retardation of the progression of diabetic nephropathy. 
These results suggest the potential therapeutic usefulness of Kampo medicines as a treatment for diabetic 
nephropathy. It is believed that their actions may occur through different mechanisms. 
28) Yokozawa T., Tanaka T., and Kimura T.: Examination of the nitric oxide production-
suppressing component in Tinospora tuberculata. Biol. Pharm. Bull., 24: 1153・1156,2001. 
The component of aqueous Tinospora tuberculata extract that inhibits nitric oxide (NO) production was examined 
using macrophages activated by the addition of lipopolysaccharide. The aqueous extract was partitioned with ethyl 
acetate. The aqueous layer was fractionated with a Diaion column. The residue of the aqueous extract was extracted 
with methanol, and partitioned with ethyl acetate. The ethyl acetate layer was found to be associated with a distinct 
decrease in the NO level and inducible NO synthase. On further fractionation, the subfraction of E-3 showed high 
anti-NO activity. N幽trans-Feruloyltyramineisolated from E・3was identified as exhibiting strong anti-NO activity. 
This compound is the most active component of Tinospora tuberculata with respect to the suppression of NO pro-
duction. 
29) Hur J.M., Park S. J., Park J. G., Hwang Y. H., Park J. C., Yokozawa T., and Kim M. S.: 
Flavonoids from the leaves of glycine max showing anti-lipid peroxidative effect. Nat. Product 
Sci., 7: 49・52,2001. 
Anti-lipid peroxidative activity and phytochemical study on the leaves of Glycine max Meer. were investigated. The 
methanol extract of the leaves of G. max reduced the level of lipid peroxides induced by bromobenzene in vitro. 
From the leaves of this plant, apigenin, genistein 7-0－β－D-glucopyranoside, kaempferol 3・0・βーD-glucopyranoside,
and kaempferol 3・0・sophorosidewere isolated and characterized by spectral data. 
30) Yokozawa T., Nakagawa T., Wakaki K., and Koizumi F.: Animal model of diabetic 
nephropathy. Exp. Toxic. Pathol., 53: 359・363,2001. 
Injection of subtotally nephrectomized rats with streptozotocin produced metabolic abnormalities resembling 
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diabetic nephropa出yin humans. These abnormalities were hyperglycemia, hypoinsulinemia, azotemia, hypertrigly-
ceridemia and hypercholesterolemia, accompanied with an increase in glycosylated protein. Extraordinary changes 
in the urinary excretion of glucose and protein were also observed in rats that received s回 ptozotocin住eatmentafter 
subtotal nephrectomy. In addition, the level of creatinine clearance was significantly decreased. The pathological 
findings in the kidney of these rats revealed lesions of the glomerular capill紅yloops, mesangial area and Bowman’s 
capsule. Coagulation was also found in由eglomerular capillaries. Our results suggest that this rat model would be 
useful for studies of diabetic nephropathy. 
31) Yokozawa T., and Dong E.: Role of ginsenoside-Rd in cisplatin-induced renal injury: special 
reference to DNA fragmentation. Nephron, 89: 433-438, 2001. 
DNA of LLC-PK1 cells cultured with cisplatin was fragmented to produce low-molecular-weight fragments. Agarose 
gel electrophoresis of出eDNA revealed a ladder pattern characteristic of apoptosis, indicating the induction of 
apoptosis by cisplatin. However, the degree of apoptosis was lower in cells cultured with cisplatin in the presence 
of ginsenoside-Rd, and白iswas accompanied by suppressed leakage of lactic dehydrogenase into the culture me-
di um.’fhe ladder pattern was detected on electrophoresis of DNA in renal tissue samples obtained from rats given 
an intravenous i吋ectionof cisplatin. Such DNA fragmentation was less conspicuous in rats given ginsenoside”Rd 
orally for 30 days prior to cisplatin administration. Significant suppression of the DNA fragmentation was also dem-
onstrated by densitometry, and measurement of urea nitrogen and creatinine in blood also showed a marked decrease 
in their respective levels in rats administered ginsenoside-Rd. The present findings suggest that ginsenoside-Rd ame-
liorates cisplatin-induced renal injury, a process in which apoptosis is plays a central role, and thereby causes resto-
ration of renal function. 
32) Min B., Hattori M., Lee H., Kim Y .:Anticomplement activity of terpenoids from the spores 
of Ganoderma lucidum. Planta Med., 67, 811・814,2001. 
A new lanostane-type terpenoid, lucidenic acid SPl (1), was isolated from a CHCh-soluble fraction of Ganoderma 
lucidum spores together with four other known compounds (2-5). The structure of lucidenic acid SPl was deter-
mined to be 3β，7β－dihydroxy-4人14α－trimethy1-11, 15-dioxo-5α－chol・8・en-24・oicacid by spectroscopic means 
including 2D-NMR. Twelve tritepenes (1-12) isolated from G. Iucidum spores were investigated in vitro for their 
anticomplementary activity. Compounds 1-5 were inactive, whereas ganoderiol F (8), ganodermanondiol (9) and 
ganodermanontriol (10) showed a s柱。nganticomplement activity against the classical pathway (CP) of the comple・
ment system with ICso values of 4.8, 41. 7, and 17 .2 μ M, respectively. The potency of these triterpene alcohols 
(8-10) in inhibiting CP activity was improved when the number of hydroxymethyl groups on the side chain moiety 
is increased. On the other hand, ganoderic acids 1・7,which contain a carboxyl group in the side chain, and 
lucidumols A and B (11,12) had litle activity on this system. 
33) Song Q.H., Toriizuka K., Iijima K., Yabe T., Yokozawa T., and Cyong J.C.: E質ectsof 
Hokoei・to(Pugongying-Tang), a Kampo formula, on monoamine content in brain regions and 
mitogenic activity of splenic lymphocytes in ovariectomized mice. Am. J. Chin. Med., 29: 433・
443, 2001. 
Hokoei-to (Pugongying-Tang) is onc of the Kampo formulae clinically used for gynecological disturbances such as 
lack of lactation and mamm紅yswelling. We investigated the effect of Hokoei-to on the nervous and immune sys-
tems in ovariectomized micc as a climacteric disorder model. Hokoei-to suppressed the decrease of monoamines in 
the ventral hippocampus and dorsal hippocampus of ovariectomized mice. It was shown that血eHokoei-to could im-
prove the metabolic turnover of dopamine. The mitogenic activity of lymphocytes in the spleen was reduced after 
ovariectomy; a suppression of this reduced activity was observed in血egroup given Hokoei-to. 
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く〉総説 Reviewpaper 
1) Yokozawa T., and Chen C.P.: Evidence suggesting a ni佐icoxide-scavenging activity for traditional crude 
合ugs,and action mechanisms of Sanguisorbae Radix against oxidative s悦 sand aging. J. Amer. Aging 
Assoc., 24: 19・30,2001. 
く〉学会報告 Scientific presentation 
1）久保山友晴，東田千尋，越静，服部征雄，小松かっ子： Ashwagandhaエキス中の神経突起伸展成分
の同定－Withanolide Aによる軸索伸展作用一．日本薬学会第121年会， 2001,3, 27-30，札幌
2）横津隆子，柳東泳，藤井創，小砂憲一，野中源一郎：ソパの抗酸化作用．日本薬学会第121年会，
2001, 3, 27-30，札幌
3）関谷倫子，横津隆子，黒川昌彦，服部征雄，白木公康：インフルエンザウイルス感染モデルにおける温
牌湯の役割．日本薬学会第121年会， 2001,3, 27-30，札幌
4) Atef A. Abdel-Hafez，中村憲夫，服部征雄： Biotransformationof phorbol by human intestinal 
bacteria.日本薬学会第121年会， 2001,3, 27-30，札幌
5）孫全忠，中村憲夫，角田広子，馬超美， I馬挙，陳道峰，服部征雄： Kαdsurαlongipedunculαte
の新リグナン成分及びそのHIV-1プロテアーゼ阻害作用．日本薬学会第121年会， 2001,3, 27-30，札
幌
6 )*Hattori M.: Recent studies on bitter principles of Ganoderma lucidum -Isolation of new Ganoderma 
凶te中enes,their biological activity and ph紅makokinetics-. 2001, 4, Auckland, New Zealand. 
7) Park J.C., Park J. G., Hur J.M., Hatano T., Yoshida T., Miyashiro H., and Hattori M.: Anti-HIV-I protease 
activity of Korean plant resources and bioactive tannins. 11出 WorldCongress of Food Science and 
Technology, 2001, 4, Seoul, Korea. 
8) Park J. G., Hur J.M., Park J.C., Shin D .Y., Park K. Y., Kim M. S., Miyashiro H., and Hattori M.: Inhibitory 
effects of extract and phenolic compounds合omOrostachys japonicus on human immunodeficiency virus 
type 1 protease. 11th World Congress of Food Science and Technology, 2001, 4, Seoul, Korea. 
9) p紅kJ. G., Hur J.M., Rhyu D. Y., and Yokozawa T.: Radical-scavenging activity of some medicinal plants 
and phenolic compounds isolated from Rosa rugosa root on 1, l-diphenyl-2-picrylhydrazyl radical. 11由
World Congress of Food Science and Technology, 2001, 4, Seoul, Korea. 
lO)*Hattori M.: Application of biotechnology to the researches of traditional medicine. 2001 Nanjing International 
Symposium of Traditional Chinese Medicine and Ph訂macy,2001, 5, Nanjing China. 
ll)*Hattori M.: Development of anti-viral agents from natural sources. 5血InternationalSymposium of Research 
Institute of Oriental Medicine-Eastern and Western Medical Appraaches on In位actableDiseases. 2001, 5, 
Kyong-Ju, Korea. 
12）中川孝子，横津隆子：漢方方剤の Advancedglycation endproducts (AGE）形成抑制作用．第44回
日本腎臓学会学術総会， 2001,5，東京．
13）柳東泳，横津隆子：パーオキシナイトライト由来腎障害モデルを用いた温牌湯の検討．第44回日本腎
臓学会学術総会， 2001,5，東京．
14) Supinya Tewtrakul，宮代博継，服部征雄，吉永智一，藤原民雄，富森毅，木津治久，宮ー諭起範：
Inhibitory effects of flavonoids on human immunodeficiency virus type 1 (HIV-1) integrase. 
日本薬学会北陸支部第104回例会， 2001,6，金沢．
15）＊横津隆子：腎障害に対する地検の役割と機序．第7回天然、薬物研究方法論アカデミー， 2001,8，大府．
16）中川孝子，横津隆子，寺津捷年，服部征雄：糖尿病性腎症における漢方方剤の作用．第18回和漢医薬学
会大会ミニシンポジウム， 2001,8，富山．
17）石田あい，横津隆子，中川孝子，服部征雄：循環障害における黄連の役割：エンドトキシンショック
並びに高脂血症モデルを用いた検討．第18回和漢医薬学会大会， 2001,8，富山．
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18)*Yokozawa T., Rhyu D. Y., and Kim D. W.: A study of buckwheat in a renal ischemia-reperfusion model. The 
VIII International Symposium on Buckwheat, 2001, 8, Chunchon, Korea. 
19）服部征雄：腸内嫌気性菌による反応の特色とその利用．日本生薬学会第48回（2001年）年会， 2001,9, 
金沢．
20）越静，中村憲夫，服部征雄，東田千尋，小松かっ子：：Fivenew withanolide derivatives from the 
roots of Withαniαsomnifera.日本生薬学会第48回（2001年）年会， 2001,9，金沢．
21)*Yokozawa T.: The role of the active Dan Shen component, magnesium lithospermate B, in the kidney. 3rd 
International Congress of Nephrology on Integrated Traditional Chinese and Western Medicine. 2001, 9, 
Shanghai, China. 
22）中川孝子，横津隆子，寺、厚捷年：糖尿病性腎症における漢方方剤の役割．第13回腎とフリーラジカル研
究会， 2001,9，和歌山．
23) Kim H. Y., Yokozawa T., Cheigh H. S., and Choi J. S.: Antioxidant effect of isorhamnetin 3,7-di-O－β－D-
glucopyranoside from mustard leaves (Brassica juncea) on oxidative stress in streptozotocin-induced dia-
betic rats.第13回腎とフリーラジカル研究会， 2001,9，和歌山．
24)*Hattori M.: Biotransformation of epicatechin 3・0-gallateand epigallocatechin 3-0・gallateby human intesti-
nal bacteria. 2001 International Conference on 0・CHA(tea) Culture and Science, 2001, 10, Shizuoka. 
25)*Yokozawa T., Nakagawa T., Shu S., and Juneja L. R.: Protective effects of green tea polyphenols against 
renal disease. 2001 International Conference on 0・CHA(tea) Culture and Science, 2001, 10, Shizuoka. 
26）＊服部征雄：和漢薬成分の代謝：最近の進歩．第22回和漢薬研究所特別セミナー， 2001, 10，富山．
27)*Hattori M.: Metabolic activation of pro-estrogenic substances by human intestinal bacteria. International 
Symposium on Strategic Goals of Pharmacognostical Studies During the 21st Century, 2001, 10, Beijing. 
28) Min B., Gao J., Hattori M., Kim Y., Bae K., Kim J., Kwon 0., Oh S., Lee H.: Anti-complement of terpenoids 
from the spores of Ganoderma lucidum.漢薬学会， 2001,10，淑明．
29) Min B., Gao J., Ahn E., Nakamura N., Hattori M., Lee H.: New triterpene aldehydes, lucialdehydes A-C, 
from Ganoderma lucidum and their cytotoxicity ag国nstmurine and human tumor cells.漢薬学会， 2001,10, 
淑明．
30) Park J. C., Hur J. M., Park J. G., Hwang Y. H., Choi D. R., Jung D. Y., Kim M. S., Kim S. N., Choi J. W., 
and Yokozawa T.: Antihepatotoxic activity and phytochemical study on Rosa davurica. International 
Symposium on Pharmaceutical Sciences Commemorating the 50th Anniversary of the Pharmaceutical 
Society of Korea, 2001, 10, Seoul, Korea. 
31) Park J.C., Rhyu D. Y., and Yokozawa T.: Inhibitory effects of Rosa rugosa加 d'Zant ho.砂Zurnp伊eritumon 
DPPH radical and their bioactive constituents. Korean Society of Medicinal Crop Science International 
Symposium 2001, 2001, 11, Daejeon, Korea. 
32）条美智子，中村憲夫，小松かっ子，服部征雄，黒川昌彦，白木公康：抗日sv活性を指標とした中国少
数民族薬物の探索．日本薬学会北陸支部第105回例会， 2001, 11，金沢．
33)*Hattori M.: Chemical and biological evaluation of the fruiting bodies of Ganoderma lucidum. The 8th 
International Symposium for Development of Advanced Materials from Resources Plants, 2001, 11, 
Kwangju, Korea. 
34) Park J.C., Hyun K. H., Rhyu D. Y., and Yokozawa T.: Potent radical-scavenging compounds isolated from 
Rosa davurica on DPPH radical. International Symposium on Food, Nutrition and Health for 21st Century, 
2001, 12, Seoul, Korea. 
（＊印は招待講演を示す）
く〉講演会 Lectures 
1 ) Hattori M.: Recent studies on metabolic transformation of natural products by human intestinal bacteria. 
71 
Dalian Institute of Chemical Physics, Chinese Academy of Science. 2001, 5, Dalian, China. 
2）服部征雄：最近の霊芝研究，富山漢方会， 2001,6，富山．
3）服部征雄：伝統医学に明日を求めて，韮山高等学校文化講演会， 2001,11，韮山．
4 ) Hattori M.: Se紅chingfor anti-HIV agents among medicinal plants. 2001, 12, Chulalongkom University, 
Bangkok. 
5) Yokozawa T.: Action mechanisms of Sanguisorbae Radix against oxidative stress and aging. 2001, 10, Pusan 
National University, Pusan, Korea 
く〉その他 Others 
1）服部征雄：エイズウイルスに効く伝統薬物をもとめて．第6回和漢薬研究所夏期セミナー， 2001,8，富
山．
2) Hattori M.: Metabolism of epicatechin 3・0・gallateand epigallocatechin 3・0・gallateby human intestinal flora. 
Proceedings of International conference on 0・Cha(ter) culture組 dsiences. Section II. Heal出 andBenefits. 
pp. 38-41, 2001. 
3) Yokozawa T., Rhyu D. Y., and Kim D. W.: A study of buckwheat in a renal ischemia-reperfusion model. 
Advances in Buckwheat Research, 583・586,2001. 
4) Chung H. Y., Soung D. Y., Kye I. S., Shim K. H., Kim Y. J., and Yokozawa, T.: Green tea tannin: potent 
peroxyni佐ite-scavengers.Proceedings of International Forum on Traditional Medicine, 201・212,2001. 
5) Yokozawa T., Nakagawa T., Shu S., and Juneja L. R.: Protective effects of green tea polyphenol against renal 
disease. Proceedings of 2001 International Conference on 0・CHA(tea)Culture and Science, 22・25,2001. 
6）横津隆子：老化促進モデルマウス（SAM）を用いての薬用人参サポニン Rdの評価.The GINSENG 
REVIEW, No. 29, 5-8, 2001. 
7）横津隆子（代表）：抗酸化物としての羅布麻の探索．文部科学省科学研究費補助金（基盤研究C）研究成
果報告書， 2001,3. 
8）横津隆子（分担）：老化・老年病に対する栄養学的・薬理学的・分子遺伝学的手法による干渉に関する総
合的研究厚生科学研究費補助金長寿科学総合研究事業研究成果報告書， 2001,3. 
く〉共同研究 Co-operative researches 
1）小松かっ子：薬効解析センター，「痴呆脳に対するコーヒーの作用」
2）下遠野邦忠：京都大学ウイルス研究所，「C型肝炎RNAポリメラーゼ阻害活性を指標とした抗HCV
剤の開発研究」
3）白木公康，小松かっ子：富山医科薬科大学医学部および和漢薬研究所，「抗へルペスウイルス作用を指
標とした中国少数民族薬物の探索J
4)大竹徹：大阪府立公衆衛生研究所，「天然からの抗エイズウイルス薬の開発J
5）木谷健一：国立療養所中部病院長寿医療研究センター，「抗老化薬に関する研究」
6）鄭海泳：釜山大学校薬学大学，「抗酸化物に関する研究」
7）田中 隆：長崎大学薬学部，「活性成分に関する研究」
8）小砂憲一：アミノアップ化学，「機能性食品の開発研究」
く〉研究費取得状況 Acquisition of research funds 
1）日本学術振興会特別研究員奨励費「微生物を利用した新しい薬物の開発」（継続，服部代表） 100万円．
2）文部科学省科学研究費基盤研究（A)(1)「高次脳機能障害モデルの作出，新規薬効一割面法の確立と創薬」
（継続，服部分担） 50万円．
3）平成13年度教育研究学内特別経費「生薬配糖体の特性を生かした大腸送達性プロドラッグの創製一漬
傷性大腸炎治療薬への展開－」（新規，服部分担） 18万円．
72 
4）平成13年度教育研究学内特別経費「アトピー性皮膚炎モデルにおける漢方方剤・食餌脂肪酸の有効性の
作用機構および活性成分の検索J（新規，服部分担） 18万円．
5）厚生省長寿科学総合研究費「老年・老年病に対する栄養学的・薬理学的・分子遺伝学的手法による干渉
に関する総合的研究J（継続，横漂分担） 250万円．
6）つくし奨学・研究基金「NOを中心としたラジカルの相互作用と和漢薬の関与」（継続，横津代表） 120 
万円．
7) 2001年度目中医学協会助成金「糖尿病性腎症に有効な伝統薬物の探索」（新規，横津代表） 100万円．
8）興和生命科学振興財団「抗HIV活性を有するホルボールエステル類の探索研究」（新規，中村代表）
100万円．
9）漢方医薬研究振興財団「C型肝炎ウイルスの抗ウイルス剤の開発研究－HCVのポリメラーゼに対して
阻害活性を示す中国少数民族薬物の探索一」（新規，中村代表） 50万円．
く〉学位および論文名 Academic degrees and曲目白
博士： SupinyaTewtrakul「Inhibitoryeffects of Thai medicinal plants，出町constituentsand related compounds 
on HIV-1 integrase」
修士：木村貴子「チベット生薬のエイズウイルス逆転写酵素及びC型肝炎ウイルスポリメラーゼ阻害作用
について」
学士：平川暁子「霊芝苦味成分の細胞毒性及び抗腫蕩効果の検討」
山辺典子「糖尿病性腎症における八味地黄丸の影響」
く〉研究室在籍者 Research member 
4年次学生：平川暁子，山辺典子
大学院前期1年：石田あい，土屋真澄，条美智子
大学院前期2年：木村貴子， KanjanaSangul 
大学院後期1年：高江静，安恩美
大学院後期2年：謝麗華，柳東泳
大学院後期3年： SupinyaTewtr叫ml
外国人研究生：湯俊（中国），張朝鳳（中国）
外国人客員研究員：趨静（博士，中国）， Atef A. Abdel-Hafze （博士，エジプト），金賢策（韓国），
越思珠（博士，韓国），孫暁飛（中国），朴恵珍（韓国），李至淑（博士，韓国），
Ramek Marpaung （インドネシア），関 嫡善（博士，韓国）, Pannarat 
Akanitapichat （博士， タイ〉
受託研究員：八田明（博士），竹内亮
事務補佐員：新井恵子，黒岩純子
